Swiss drugs regulator Swissmedic has authorised the COVID-19 vaccine from Pfizer and partner BioNTech, the agency said on Saturday, calling it the world’s first such approval under a standard procedure. Reuters reported.
Two months after receiving the application, Swissmedic granted authorisation for the vaccine for people aged 16 and older after a rolling review of documents being submitted.
Other countries have already approved it for emergency use to help curb the global coronavirus pandemic.